TipRanks
Go Ultimate55% OFF

MedGen (MDIN) Financial Statements

MedGen Financial Overview

MedGen's market cap is currently $3.01K. The company's EPS TTM is ―; its P/E ratio is -600.00; MedGen has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 19
Income Statement
Total Revenue$ 0.00
Gross Profit$ 0.00
Operating Income―
EBITDA―
Net Income―
Balance Sheet
Cash & Short-Term Investments$ 0.00
Total Assets$ 0.00
Total Debt$ 24.00
Net Debt$ 24.00
Total Liabilities$ 44.00
Stockholders' Equity$ -43.00
Cash Flow
Free Cash Flow$ -14.00
Operating Cash Flow$ -14.00
Investing Cash Flow$ 0.00
Financing Cash Flow$ 10.00

Currency in USD

MedGen Earnings and Revenue History

01230 %0.4 %0.8 %1.2 %EarningsProfit Margin2019RevenueEarningsProfit Margin

MedGen Debt to Assets

02040600 %0.4 %0.8 %1.2 %LiabilitiesDebt to Assets2019AssetsLiabilitiesDebt to Assets

MedGen Cash Flow

-20-15-10-50510152019OperatingInvestingFinancing

MedGen Forecast EPS vs Actual EPS